Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
ANI Pharmaceuticals (ANIP) Stock Price & Analysis
254 Followers
ANIP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$38.91 - $70.81
Previous Close$67.25
Volume108.73K
Average Volume (3M)145.45K
Market Cap
$1.41B
Enterprise Value$1.48B
Total Cash (Recent Filing)$221.12M
Total Debt (Recent Filing)$285.67M
Price to Earnings (P/E)72.6
Beta0.93
Next Earnings
May 10, 2024Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.93
Shares Outstanding21,078,986
10 Day Avg. Volume96,462
30 Day Avg. Volume145,451
Standard Deviation0.12
R-Squared0.12
Alpha-0.00194
Financial Highlights & Ratios
Price to Book (P/B)5.73
Price to Sales (P/S)2.91
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.16
Enterprise Value/Gross Profit4.84
Enterprise Value/Ebitda17.41
Forecast
1Y Price Target
$80.00Price Target Upside18.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
ANI Pharmaceuticals News
PremiumCompany Announcements
ANI Pharmaceuticals Financial Report: Key Insights Revealed
Bulls Say, Bears Say
Bulls Say
Financial ForecastThe company meaningfully raised their sales and earnings guidance for FY 2023.
Financial PerformanceANIP delivered record quarterly net revenues, EBITDA and EPS that were above expectations.
Product PerformanceThe stock reacted very positively to exceptionally strong Cortrophin Gel performance.
Bears Say
Earnings Call ImpactStock has faced significant pressure since their earnings call.
Management GuidanceInvestors are concerned due to management's comments related to softening specific market opportunities.
Sales PerformanceThe established brands segment declined dramatically.
---
Ownership Overview
41.26% Insiders
16.20% Mutual Funds
19.75% Other Institutional Investors
22.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ANIP FAQ
What was ANI Pharmaceuticals Inc’s price range in the past 12 months?
ANI Pharmaceuticals Inc lowest stock price was $38.91 and its highest was $70.81 in the past 12 months.
What is ANI Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is ANI Pharmaceuticals Inc’s upcoming earnings report date?
ANI Pharmaceuticals Inc’s upcoming earnings report date is May 10, 2024 which is tomorrow.
How were ANI Pharmaceuticals Inc’s earnings last quarter?
ANI Pharmaceuticals Inc released its earnings results on Feb 29, 2024. The company reported $1 earnings per share for the quarter, beating the consensus estimate of $0.855 by $0.145.
Is ANI Pharmaceuticals Inc overvalued?
According to Wall Street analysts ANI Pharmaceuticals Inc’s price is currently Undervalued.
Does ANI Pharmaceuticals Inc pay dividends?
ANI Pharmaceuticals Inc does not currently pay dividends.
What is ANI Pharmaceuticals Inc’s EPS estimate?
ANI Pharmaceuticals Inc’s EPS estimate is $1.
How many shares outstanding does ANI Pharmaceuticals Inc have?
ANI Pharmaceuticals Inc has 20,980,307 shares outstanding.
What happened to ANI Pharmaceuticals Inc’s price movement after its last earnings report?
ANI Pharmaceuticals Inc reported an EPS of $1 in its last earnings report, beating expectations of $0.855. Following the earnings report the stock price went up 12.259%.
Which hedge fund is a major shareholder of ANI Pharmaceuticals Inc?
Among the largest hedge funds holding ANI Pharmaceuticals Inc’s share is Defender Capital, LLC.. It holds ANI Pharmaceuticals Inc’s shares valued at 1M.
---
ANI Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$80.00 (18.96% Upside)
$80.00 (18.96% Upside)
Blogger Sentiment
Bullish
ANIP Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 7.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 3.8%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.49%
12-Months-Change
Fundamentals
Return on Equity
4.87%
Trailing 12-Months
Asset Growth
17.43%
Trailing 12-Months
Company Description
ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
---
ANIP Earnings Call
Q4 2024
0:00 / 0:00
---
ANIP Stock 12 Month Forecast
Average Price Target
$80.00
▲(18.96% Upside)
Technical Analysis
Best Analysts Covering ANIP
1 Year
1 Year Success Rate
19/30 ratings generated profit
1 Year Average Return
+14.14%
reiterated a buy rating a year ago
Copying Elliot Wilbur's trades and holding each position for 1 Year would result in 63.33% of your transactions generating a profit, with an average return of +14.14% per trade.
---